AGL 40.10 Increased By ▲ 0.10 (0.25%)
AIRLINK 130.70 Increased By ▲ 1.17 (0.9%)
BOP 6.80 Increased By ▲ 0.12 (1.8%)
CNERGY 4.60 Decreased By ▼ -0.03 (-0.65%)
DCL 8.97 Increased By ▲ 0.03 (0.34%)
DFML 43.01 Increased By ▲ 1.32 (3.17%)
DGKC 84.02 Increased By ▲ 0.25 (0.3%)
FCCL 32.87 Increased By ▲ 0.10 (0.31%)
FFBL 78.45 Increased By ▲ 2.98 (3.95%)
FFL 12.28 Increased By ▲ 0.81 (7.06%)
HUBC 110.90 Increased By ▲ 0.35 (0.32%)
HUMNL 14.56 No Change ▼ 0.00 (0%)
KEL 5.60 Increased By ▲ 0.21 (3.9%)
KOSM 8.30 Decreased By ▼ -0.10 (-1.19%)
MLCF 39.75 Decreased By ▼ -0.04 (-0.1%)
NBP 61.75 Increased By ▲ 1.46 (2.42%)
OGDC 199.94 Increased By ▲ 0.28 (0.14%)
PAEL 26.59 Decreased By ▼ -0.06 (-0.23%)
PIBTL 7.80 Increased By ▲ 0.14 (1.83%)
PPL 160.30 Increased By ▲ 2.38 (1.51%)
PRL 26.73 No Change ▼ 0.00 (0%)
PTC 18.75 Increased By ▲ 0.29 (1.57%)
SEARL 83.07 Increased By ▲ 0.63 (0.76%)
TELE 8.23 Decreased By ▼ -0.08 (-0.96%)
TOMCL 34.48 Decreased By ▼ -0.03 (-0.09%)
TPLP 9.05 Decreased By ▼ -0.01 (-0.11%)
TREET 16.99 Decreased By ▼ -0.48 (-2.75%)
TRG 60.50 Decreased By ▼ -0.82 (-1.34%)
UNITY 27.90 Increased By ▲ 0.47 (1.71%)
WTL 1.42 Increased By ▲ 0.04 (2.9%)
BR100 10,590 Increased By 183.2 (1.76%)
BR30 31,987 Increased By 273.8 (0.86%)
KSE100 98,784 Increased By 1455.8 (1.5%)
KSE30 30,756 Increased By 563.4 (1.87%)

KARACHI: Roche Diagnostics Pakistan has introduced an innovative product CoaguChek INRange for the patients on warfarin therapy, enabling them to frequently check their International normalized ratio (INR) values conveniently and easily share the results with their consultant via their phone or any other computing device for quick and efficient therapy management.

CoaguChek INRange in partnership with Dawaai.pk will enable users to easily get their result in just one minute by a single drop of blood. This solution will save patients, especially the bed ridden and elderly ones from the hassle of going to the laboratory for testing over and over again followed by visits to their consultants.

According to research conducted by Australian Point of Care Practitioners and Integrated Cardiovascular Clinical Network, Country Health South Australia, published in US National Library of Medicine, National Institutes Health USA, regular monitoring of the anticoagulant effect is required and evidence suggests that patients who self-monitor using point-of-care testing have better outcomes than other patients. With this solution, patients can easily perform the test at their convenience anywhere. This solution is available nationwide at dawaai.pk where professional pharmacists and consultants are available to guide and educate the patients.

Copyright Business Recorder, 2021

Comments

Comments are closed.